Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 9,467,383 | $62.88 | $595M | — | — | |
| FLR - Fluor | New | 3,819,580 | $51.27 | $196M | +3,819,580 | +$196M | |
| CNR - Core Natural Resources | Reduce −2.4% | 2,155,640 | $69.74 | $150M | −53,000 | −$20M | |
| BHF - Brighthouse Finl | Reduce −1.5% | 2,760,097 | $53.77 | $148M | −41,000 | −$14M | |
| KD - Kyndryl | Reduce −19.9% | 3,311,297 | $41.96 | $139M | −823,910 | +$9M | |
| PENN - Penn Entertainment | Add +19.6% | 7,494,440 | $17.87 | $134M | +1,226,000 | +$32M | |
| CNH - Cnh Indl | Reduce −2.5% | 7,872,610 | $12.96 | $102M | −203,930 | +$3M | |
| PKG - Graphic Packaging | Add +349.4% | 4,705,950 | $21.07 | $99M | +3,658,850 | +$72M | |
| DHT — | Add +15.3% | 7,620,934 | $10.81 | $82M | +1,010,000 | +$13M | |
| TECK - Teck Resources · CL B | Hold | 2,000,000 | $40.38 | $81M | — | — | |
| HPQ - HP | Hold | 3,018,770 | $24.46 | $74M | — | — | |
| TEVA - Teva Pharmaceutical Inds | Add +565.0% | 3,778,777 | $16.76 | $63M | +3,210,577 | +$55M | |
| CPRI - Capri | Hold | 3,479,107 | $17.70 | $62M | — | — | |
| LBTYA - Liberty Global · CL A | Hold | 5,220,502 | $10.01 | $52M | — | — | |
| GLD - Spdr Gold Tr | Reduce −6.0% | 169,411 | $304.83 | $52M | −10,740 | −$267K | |
| ROIV - Roivant Sciences | Reduce −16.4% | 4,551,057 | $11.27 | $51M | −890,110 | −$4M | |
| WFRD - Weatherford Intl | Add +110.4% | 960,810 | $50.31 | $48M | +504,171 | +$24M | |
| CNC - Centene Del | Add +53.3% | 839,170 | $54.28 | $46M | +291,600 | +$12M | |
| SDRL - Seadrill | Hold | 1,588,828 | $26.25 | $42M | — | — | |
| CI - The Cigna Group | New | 93,750 | $330.58 | $31M | +93,750 | +$31M | |
| ACHC — | Add +615.7% | 865,011 | $22.69 | $20M | +744,151 | +$16M | |
| VSXY - Victorias Secret And | New | 887,750 | $18.52 | $16M | +887,750 | +$16M | |
| LKFT - Galapagos | Hold | 482,746 | $27.99 | $14M | — | — | |
| COYA - Coya Therapeutics | Hold | 1,646,440 | $5.75 | $9M | — | — | |
| SNX - Td Synnex | Reduce −28.0% | 33,270 | $135.70 | $5M | −12,945 | −$290K | |
| GDX - Vaneck ETF Trust | Hold | 76,460 | $52.06 | $4M | — | — | |
| OIH - Vaneck ETF Trust | Add +29.0% | 15,940 | $230.29 | $4M | +3,580 | +$431K | |
| SHC - Sotera Health | New | 233,690 | $11.12 | $3M | +233,690 | +$3M | |
| GPRO - Gopro · CL A | Hold | 2,823,100 | $0.7573 | $2M | — | — | |
| PTON - Peloton Interactive · CL A | Reduce −96.4% | 179,470 | $6.94 | $1M | −4,823,938 | −$30M | |
| GANX - Gain Therapeutics | Hold | 566,130 | $1.80 | $1M | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.95 | $68K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2025 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| VTRS - Viatris | Exit | 0 | $8.71 | $52M | −6,000,830 | −$52M | |
| DLTR - Dollar Tree | Exit | 0 | $75.07 | $33M | −436,360 | −$33M | |
| ALITEUR - Alight · CL A | Exit | 0 | $5.93 | $6M | −1,000,000 | −$6M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2